These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24120957)

  • 1. Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys.
    Marco MR; Dons EM; van der Windt DJ; Bhama JK; Lu LT; Zahorchak AF; Lakkis FG; Cooper DK; Ezzelarab MB; Thomson AW
    Transpl Immunol; 2013 Dec; 29(1-4):88-98. PubMed ID: 24120957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys.
    Van Der Windt DJ; Smetanka C; Macedo C; He J; Lakomy R; Bottino R; Ekser B; Echeverri GJ; Metes D; Ijzermans JNM; Trucco M; Cooper DKC; Lakkis FG
    Am J Transplant; 2010 Apr; 10(4):773-783. PubMed ID: 20420638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity.
    Dons EM; Raimondi G; Zhang H; Zahorchak AF; Bhama JK; Lu L; Ezzelarab M; Ijzermans JN; Cooper DK; Thomson AW
    Am J Transplant; 2013 Aug; 13(8):2169-78. PubMed ID: 23635093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
    von Kutzleben S; Pryce G; Giovannoni G; Baker D
    Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte depletion and repopulation in peripheral blood and small intestine of cynomolgus monkeys after alemtuzumab treatment.
    Shan T; Qu L; Zhang J; Li Q; Shen B; Gu L; Jiang J; Feng X; Li N; Li J
    J Surg Res; 2011 May; 167(1):e21-7. PubMed ID: 20888596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).
    Kirk AD; Hale DA; Mannon RB; Kleiner DE; Hoffmann SC; Kampen RL; Cendales LK; Tadaki DK; Harlan DM; Swanson SJ
    Transplantation; 2003 Jul; 76(1):120-9. PubMed ID: 12865797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.
    Ezzelarab MB; Zhang H; Guo H; Lu L; Zahorchak AF; Wiseman RW; Nalesnik MA; Bhama JK; Cooper DK; Thomson AW
    Am J Transplant; 2016 Jul; 16(7):1999-2015. PubMed ID: 26700196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.
    Trzonkowski P; Zilvetti M; Chapman S; Wieckiewicz J; Sutherland A; Friend P; Wood KJ
    Am J Transplant; 2008 Feb; 8(2):338-47. PubMed ID: 18211507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface.
    Lee F; Luevano M; Veys P; Yong K; Madrigal A; Shaw BE; Saudemont A
    PLoS One; 2014; 9(7):e103254. PubMed ID: 25050704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.
    Dalakas MC; Rakocevic G; Schmidt J; Salajegheh M; McElroy B; Harris-Love MO; Shrader JA; Levy EW; Dambrosia J; Kampen RL; Bruno DA; Kirk AD
    Brain; 2009 Jun; 132(Pt 6):1536-44. PubMed ID: 19454532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune profile of pediatric renal transplant recipients following alemtuzumab induction.
    De Serres SA; Mfarrej BG; Magee CN; Benitez F; Ashoor I; Sayegh MH; Harmon WE; Najafian N
    J Am Soc Nephrol; 2012 Jan; 23(1):174-82. PubMed ID: 22052056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation.
    Meyer RG; Wagner EM; Konur A; Bender K; Schmitt T; Hemmerling J; Wehler D; Hartwig UF; Roosnek E; Huber C; Kolbe K; Herr W
    Bone Marrow Transplant; 2010 Apr; 45(4):668-74. PubMed ID: 19684624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.
    Ayasoufi K; Fan R; Fairchild RL; Valujskikh A
    J Immunol; 2016 Apr; 196(7):3180-90. PubMed ID: 26912319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation?
    Simpson D
    BioDrugs; 2003; 17(3):147-54. PubMed ID: 12749751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.
    Kanda Y; Oshima K; Kako S; Fukuda T; Uchida N; Miyamura K; Kondo Y; Nakao S; Nagafuji K; Miyamoto T; Kurokawa M; Okoshi Y; Chiba S; Ohashi Y; Takaue Y; Taniguchi S
    Am J Hematol; 2013 Apr; 88(4):294-300. PubMed ID: 23450467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.
    Ezzelarab MB; Lu L; Guo H; Zahorchak AF; Shufesky WF; Cooper DK; Morelli AE; Thomson AW
    Transplantation; 2016 Jan; 100(1):91-102. PubMed ID: 26680373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire.
    Battaglia A; Ferrandina G; Buzzonetti A; Malinconico P; Legge F; Salutari V; Scambia G; Fattorossi A
    Immunology; 2003 Nov; 110(3):304-12. PubMed ID: 14632657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipients.
    Ezzelarab MB; Zhang H; Sasaki K; Lu L; Zahorchak AF; van der Windt DJ; Dai H; Perez-Gutierrez A; Bhama JK; Thomson AW
    Transplantation; 2021 Sep; 105(9):1965-1979. PubMed ID: 33587433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52).
    Osterborg A; Werner A; Halapi E; Lundin J; Harmenberg U; Wigzell H; Mellstedt H
    Eur J Haematol; 1997 Jan; 58(1):5-13. PubMed ID: 9020367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Human Mutant TGFβ1/Fc Protein on Memory and Regulatory T Cell Homeostasis Following Lymphodepletion in Nonhuman Primates.
    Guo H; Lu L; Wang R; Perez-Gutierrez A; Abdulkerim HS; Zahorchak AF; Sumpter TL; Reimann KA; Thomson AW; Ezzelarab MB
    Am J Transplant; 2016 Oct; 16(10):2994-3006. PubMed ID: 27217298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.